Workflow
Schwab 1000 Index ETF
icon
Search documents
X @Herbert Ong
Herbert Ong· 2025-11-03 23:47
Proxy Voting Issue - Schwab is facing pressure to change its proxy vote for Tesla in their ETFs to align with the Board's recommendations [1] - The request includes rejecting the guidance of GlassLewis [1] ETFs in Question - The ETFs involved are Schwab U S Broad Market ETF, Schwab U S Large-Cap ETF, Schwab U S Large-Cap Growth ETF, Schwab Fundamental U S Broad Market ETF, Schwab Fundamental U S Large Company ETF, and Schwab 1000 Index ETF [2] Contact Information - General inquiries can be directed to (877) 566-4945, while private client services can be reached at (866) 855-9102 [1]
How The Parts Add Up: SCHK Headed For $35
Nasdaq· 2025-09-15 10:18
Core Viewpoint - Analysts project a 10.55% upside for the Schwab 1000 Index ETF (SCHK) based on the average target prices of its underlying holdings, indicating potential growth in the ETF's value [1][2]. Summary by Category ETF Performance - The Schwab 1000 Index ETF (SCHK) is currently trading at $31.75 per unit, with an implied analyst target price of $35.10 per unit, suggesting a potential upside of 10.55% [2][3]. Underlying Holdings - Notable underlying holdings with significant upside potential include: - QXO Inc (Symbol: QXO) with a recent price of $20.77 and an average analyst target of $33.73, representing a 62.38% upside [2][3]. - SPS Commerce, Inc. (Symbol: SPSC) trading at $105.53, with a target price of $157.54, indicating a 49.29% upside [2][3]. - BridgeBio Pharma Inc (Symbol: BBIO) at a recent price of $51.21, with a target of $64.67, showing a 26.28% upside [2][3]. Analyst Target Justification - Questions arise regarding whether analysts' targets are justified or overly optimistic, considering recent company and industry developments. A high target relative to current trading prices may reflect optimism but could also lead to potential downgrades if targets are outdated [3].